
Criglim P 2mg/500mg/15mg Tablet
Marketer
Crimson Pharmaceuticals LLP
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Criglim P 2mg/500mg/15mg Tablet
Glimepiride-Metformin-Pioglitazone 2mg/500mg/15mg tablets are a triple-combination medication managing blood glucose. This formulation, used alongside diet and exercise, enhances glycemic control in adults with type 2 diabetes. It improves insulin effectiveness, subsequently reducing blood sugar. Dosage and frequency should strictly adhere to your physician's instructions. Administer with food to minimize gastrointestinal discomfort. If a dose is missed, take it promptly unless nearing the next scheduled dose; in that case, omit the missed dose and resume the regular regimen. Never double the dose. Excessive intake can cause hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol, or skipped meals may increase hypoglycemia risk; regular blood glucose monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencement, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function will be assessed before treatment begins. Limit alcohol consumption to mitigate the risk of side effects.
Uses of Criglim P 2mg/500mg/15mg Tablet
Managing Type 2 diabetes
Major Benefits of Criglim P 2mg/500mg/15mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Consume Criglim P 2mg/500mg/15mg Tablet with food.
Common Side effects of Criglim P 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Criglim P 2mg/500mg/15mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or dividing it. Consumption of the Criglim P 2mg/500mg/15mg Tablet should coincide with a meal.
How Criglim P 2mg/500mg/15mg Tablet works:
Criglim P tablets (2mg/500mg/15mg) combine three distinct antidiabetic agents: glimepiride, metformin, and pioglitazone. This triple-drug approach improves blood glucose management when single or dual-agent therapies prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further amplifies the body's responsiveness to insulin.
SAFETY ADVICE
AlcoholUNSAFE
Combining Criglim P 2mg/500mg/15mg tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Criglim P 2mg/500mg/15mg Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against potential dangers prior to prescribing. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
The use of Criglim P 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Criglim P 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should exercise caution when using Criglim P 2mg/500mg/15mg tablets, potentially requiring dosage modification. Medical advice is recommended. Criglim P 2mg/500mg/15mg tablets are unsuitable for individuals with severe hepatic dysfunction.
What if you forget to take Criglim P 2mg/500mg/15mg Tablet :
Should you forget to take a Criglim P 2mg/500mg/15mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Criglim P 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes medication |
